Concentrix Corporation (CNXC)
NASDAQ: CNXC · Real-Time Price · USD
32.65
+0.69 (2.16%)
Nov 11, 2026, 11:31 AM EST - Market open

Concentrix Income Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Aug '26 May '26 Feb '26 Nov '25 Aug '25 May '25 Feb '25 Nov '24 Aug '24 May '24 Feb '24 Nov '23 Aug '23 May '23 Feb '23 Nov '22 Aug '22 May '22 Feb '22 Nov '21
2,4542,4622,5002,5532,4832,4172,3722,4482,3872,3812,4032,2311,6331,6151,6361,6411,5801,5681,5361,467
Revenue Growth (YoY)
-1.19%1.87%5.40%4.29%4.01%1.54%-1.27%9.74%46.21%47.44%46.83%35.96%3.37%2.97%6.53%11.87%13.05%14.47%13.51%12.74%
Cost of Revenue
1,5771,5961,6511,6771,6281,5691,5161,5771,5231,5231,5461,4081,0391,0341,0551,0471,0131,009997.92947.24
Gross Profit
876.75866.02849.66875.96855.01848.15855.9870.6864.19857.57856.53822.86593.69580.23581.16593.37566.85558.92538.13519.37
Selling, General & Admin
599.69633.11590.91681.85596.41590.76561.82720.71557.76560.43678.04396412.11409.13417.59240.05393.55399.49389.96242.18
Amortization of Goodwill & Intangibles
100.91102.06103.46107.78111.78109.16105.62110.1116.56115.97-214.83---162.67---136.94
Operating Expenses
700.6735.16694.37789.62708.19699.92667.44830.81674.31676.4678.04610.83412.11409.13417.59402.72393.55399.49389.96379.11
Operating Income
176.15130.86155.2986.33146.82148.23188.4639.79189.88181.17178.49212.02181.58171.1163.57190.65173.3159.43148.18140.25
Interest Expense
-64.86-68.07-69.05-69.94-72.01-75.41-72.99-76.12-80.82-82.46-4.18-96.06-35.58-35.37-33.99-28.06-20.27-12.97-8.77-3.73
Currency Exchange Gain (Loss)
-2.6129.47-1.86-21.2135.7-197.536.13-34.029.950.46-2.1-2.99-8.24.242.03-42.55-16.94-0.52-7.53
Other Non Operating Income (Expenses)
-3.378.94-14.9326.7-1.476.58-6.17-2.21-2.082.69-86.67-6.62-1.9410.15-9.9416.551.4518.698.6313.56
EBT Excluding Unusual Items
105.32101.1969.4521.89109.0360.41116.79-2.4172.97111.3588.1107.24141.08137.67123.89181.12161.92148.21147.51142.55
Merger & Restructuring Charges
-31.43-25.35-34.8753.45---18.0297.13-36.06-30.91-30.17-14.45-34.27-31.7-5.54-18.55-12.57-1.73-0.92-0.83
Impairment of Goodwill
-1,050---1,523----------------
Gain (Loss) on Sale of Assets
-1.53-6.89-----------------13.2
Asset Writedown
----4.46----------------
Other Unusual Items
-2.130.53-5.856.212.42-8.692.0218.18-10.56.6914.9-15.68--------
Pretax Income
-979.7669.4828.73-1,446111.4451.72100.79112.9126.4287.1372.8277.11106.81105.97118.34162.57149.36146.48146.59154.92
Income Tax Expense
8.3514.27.1433.2123.339.6330.54-2.749.7920.2920.727.6229.1727.1230.4757.6342.2433.4536.0530.81
Earnings From Continuing Operations
-988.1155.2821.59-1,47988.1142.0970.26115.6516.6366.8352.169.4977.6478.8587.87104.94107.12113.03110.54124.11
Minority Interest in Earnings
-----------------0.430.11-0.27-
Net Income
-988.1155.2821.59-1,47988.1142.0970.26115.6516.6366.8352.169.4977.6478.8587.87104.94106.69113.14110.27124.11
Preferred Dividends & Other Adjustments
1.121.161.19-5.614.222.043.424.630.562.5721.81.291.361.561.781.581.711.551.79
Net Income to Common
-989.2354.1220.4-1,47483.8940.0666.84111.0216.0764.2650.167.6876.3577.4986.31103.16105.11111.43108.72122.32
Net Income Growth (YoY)
-35.10%-69.47%-421.97%-37.66%33.41%64.03%-78.95%-17.07%-41.96%-34.39%-27.36%-30.46%-20.61%-15.66%-2.75%36.50%23.89%89.26%
Shares Outstanding (Basic)
6161616263636464656566625151515151525252
Shares Outstanding (Diluted)
6161616263636464656566625151515152525252
Shares Change (YoY)
-2.86%-4.01%-4.32%-3.55%-3.16%-2.95%-2.62%3.87%26.44%27.13%27.81%20.56%-0.66%-1.15%-1.09%-1.20%-0.98%-0.03%0.46%0.80%
EPS (Basic)
-16.240.890.33-23.741.340.631.041.730.250.980.761.091.501.511.692.022.052.162.112.37
EPS (Diluted)
-16.240.890.33-23.741.340.631.041.730.250.980.761.091.491.511.682.012.042.142.092.35
EPS Growth (YoY)
-40.77%-68.37%-439.01%-35.77%37.00%57.92%-83.35%-34.77%-54.59%-45.58%-26.88%-29.65%-19.73%-14.63%-1.80%36.53%23.32%88.14%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Aug '26 May '26 Feb '26 Nov '25 Aug '25 May '25 Feb '25 Nov '24 Aug '24 May '24 Feb '24 Nov '23 Aug '23 May '23 Feb '23 Nov '22 Aug '22 May '22 Feb '22 Nov '21
Free Cash Flow
221.23209.72-137.12281.19159.75180.74-49.21224.53128.88178.25-102.93164.45167.48101.2564.3192.94126.45141.7-0.38145.84
Free Cash Flow Per Share
3.633.45-2.244.532.552.85-0.773.491.992.73-1.562.653.271.971.253.752.452.73-0.012.80
Dividend Per Share
0.3600.3600.3600.3600.3330.3330.3330.3330.3020.3020.3020.3020.2750.2750.2750.2750.2500.2500.2500.250
Dividend Growth (YoY)
8.19%8.19%8.19%8.19%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%----
Gross Margin
35.73%35.17%33.98%34.31%34.43%35.09%36.08%35.56%36.20%36.02%35.65%36.89%36.36%35.93%35.52%36.17%35.88%35.64%35.03%35.41%
Operating Margin
7.18%5.31%6.21%3.38%5.91%6.13%7.94%1.63%7.95%7.61%7.43%9.50%11.12%10.60%10.00%11.62%10.97%10.17%9.65%9.56%
Profit Margin
-40.32%2.20%0.82%-57.73%3.38%1.66%2.82%4.54%0.67%2.70%2.08%3.03%4.68%4.80%5.27%6.29%6.65%7.11%7.08%8.34%
Free Cash Flow Margin
9.02%8.52%-5.48%11.01%6.43%7.48%-2.07%9.17%5.40%7.49%-4.28%7.37%10.26%6.27%3.93%11.76%8.00%9.04%-0.03%9.94%
EBITDA
333.64290.98314.66252.19315.37313.54349.17208.51366358.11362.55367.49259.34248.73241.01269.05251.73238.03222.27208.86
EBITDA Margin
13.60%11.82%12.58%9.88%12.70%12.97%14.72%8.52%15.33%15.04%15.09%16.47%15.88%15.40%14.73%16.40%15.94%15.18%14.47%14.24%
D&A For EBITDA
157.48160.12159.37165.85168.56165.31160.72168.72176.12176.94184.06155.4777.7677.6477.4478.478.4378.6174.0968.61
EBIT
176.15130.86155.2986.33146.82148.23188.4639.79189.88181.17178.49212.02181.58171.1163.57190.65173.3159.43148.18140.25
EBIT Margin
7.18%5.31%6.21%3.38%5.91%6.13%7.94%1.63%7.95%7.61%7.43%9.50%11.12%10.60%10.00%11.62%10.97%10.17%9.65%9.56%
Effective Tax Rate
-20.44%24.86%-20.94%18.62%30.29%-37.04%23.29%28.46%9.89%27.31%25.59%25.75%35.45%28.28%22.84%24.59%19.89%
SEC Filings: 10-K · 10-Q